Barnaby Pickering
Reporter, Medtech Insight
Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.
Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.
Latest From Barnaby Pickering
Start-up Spotlight: AMT Tackles Melanoma Diagnosis With AI
Stockholm-based AI Medical Technology is developing Dermalyser, which can help doctor’s diagnose skin cancer using images of moles and lesions. The company is initially focused on Sweden and the Netherlands, but hopes to soon expand into new European markets and the US.
Cyted’s Sponge On A String May Help Diagnose Esophageal Cancer
Cyted is using Medtronic’s cytosponge collection device combined with its own analysis platform to create a simple and cheap method to screen patients for early warning signs of esophageal cancer.
Digital Health Roundup: AI Trends In Medtech; Exec Chats; FDA’s Digital Health Guru Steps Down
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights AI trends in medtech, Exec Chats with iRhythm and medical robotics authority Moshe Shoham, and key FDA updates.
Upgraded Paige Suite Gains CE-IVD and UKCA Marks
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment
In this edition of Report Digest, UK-based reporter Barnaby Pickering talks about the prostate cancer diagnostics and minimally invasive treatments markets with analyst Phil Greenfield. The two discuss ongoing developments in both treatment and diagnosis, while exploring driving and limiting factors for both.
Deals Shaping The Medical Industry, April 2022
In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in April 2022. Data provided by Biomedtracker.